The book covers a diverse set of topics including the surgical and medical treatment of localized and advanced prostate cancer, advanced in radiotherapy and radiopharmaceutical treatments, imaging-based and molecular biomarkers for prediction and prognosis, personalized oncology and precision medicine approaches, basic and translational research advances in prostate cancer, and the effect of environmental exposures and metabolism on prostate cancer risk.

This book might bring some clinical surprises and unknown molecular promises to you as a reader. And you will also find that science has progressed in some areas during the time that the book was constructed. For example in missing recent outcomes of some medical trials, long term evaluations of diagnostics leading to risk based treatment approaches, newest imaging (like PSMA PET) and genetic insights that are being produced continuously. But the aim is to illustrate the great progress prostate cancer research is making in the broad field of oncology, and which issues remain controversial, unsolved, and exciting for further work.